US Stock MarketDetailed Quotes

SPRO Spero Therapeutics

Watchlist
  • 1.460
  • +0.030+2.10%
Close Apr 26 16:00 ET
  • 1.450
  • -0.010-0.68%
Post 16:16 ET
78.68MMarket Cap3.40P/E (TTM)

Spero Therapeutics Key Stats

Spero Therapeutics Earnings Date

Currency: USD

Period

Q4 FY2023 Earnings

Mar 13, 2024

Revenue(YoY)

73.52M

+54.98%
EPS(YoY)

0.97

+76.36%

Buy

Mar 13, 2024

Spero Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 600.000K--
--2024/Q1-- / 21.533M--
Mar 13, 20242023/Q473.524M / 18.633M--
Nov 13, 20232023/Q325.473M / 14.967M--
Aug 10, 20232023/Q22.716M / 1.083M--
May 11, 20232023/Q12.069M / 1.267M--
Mar 30, 20232022/Q447.441M / 22.867M--
Nov 14, 20222022/Q32.006M / 5.417M--
Aug 10, 20222022/Q21.993M / 1.433M--
May 16, 20222022/Q12.069M / 1.925M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 600.000K--
--2024/Q1-- / 21.533M--
Mar 13, 20242023/Q473.524M / 18.633M--
Nov 13, 20232023/Q325.473M / 14.967M--
Aug 10, 20232023/Q22.716M / 1.083M--
May 11, 20232023/Q12.069M / 1.267M--
Mar 30, 20232022/Q447.441M / 22.867M--
Nov 14, 20222022/Q32.006M / 5.417M--
Aug 10, 20222022/Q21.993M / 1.433M--
May 16, 20222022/Q12.069M / 1.925M--

Unlock Free Earnings Estimates

Spero Therapeutics Earnings Reports

Read more

Analysis

Analyst Rating

Updated: Mar 13, 2024

Buy

  • Buy

    50.00%
  • Hold

    50.00%
  • Sell

    0.00%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg